Pages that link to "Q40498116"
Jump to navigation
Jump to search
The following pages link to Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells (Q40498116):
Displaying 50 items.
- FOXP3 ensembles in T-cell regulation (Q24299602) (← links)
- Adoptive immunotherapy for cancer: building on success (Q24546258) (← links)
- Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy? (Q24596171) (← links)
- Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray (Q24815128) (← links)
- Melanoma: oncogenic drivers and the immune system (Q26775598) (← links)
- Immune cell promotion of metastasis (Q26991724) (← links)
- Cancer immunotherapy (Q27026870) (← links)
- The ever-expanding role of HIF in tumour and stromal biology (Q28079015) (← links)
- Cancer despite immunosurveillance: immunoselection and immunosubversion (Q28263865) (← links)
- Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma (Q28307216) (← links)
- Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity (Q28550203) (← links)
- Strategies and challenges in eliciting immunity to melanoma (Q30435893) (← links)
- Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP. (Q33238306) (← links)
- Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy (Q33282703) (← links)
- Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma. (Q33284046) (← links)
- Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo (Q33299427) (← links)
- IPEX syndrome and human Treg cells (Q33391755) (← links)
- Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma (Q33416009) (← links)
- Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer (Q33482453) (← links)
- Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients (Q33587584) (← links)
- Infiltrative T regulatory cells in enucleated uveal melanomas (Q33623491) (← links)
- The role of regulatory T cells in cancer (Q33631986) (← links)
- Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. (Q33748547) (← links)
- Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma. (Q33774580) (← links)
- Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma (Q33840446) (← links)
- Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma (Q33865610) (← links)
- Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice. (Q34044931) (← links)
- PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer (Q34073958) (← links)
- Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles (Q34079604) (← links)
- Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma (Q34099760) (← links)
- Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma (Q34111789) (← links)
- Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment (Q34114136) (← links)
- FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions (Q34197717) (← links)
- Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients. (Q34259974) (← links)
- CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells (Q34355686) (← links)
- CD4 T cells in tumor immunity (Q34427580) (← links)
- Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy (Q34447829) (← links)
- Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer (Q34527281) (← links)
- Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients (Q34538321) (← links)
- Immunologic targeting of FOXP3 in inflammatory breast cancer cells. (Q34558393) (← links)
- In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells (Q34560957) (← links)
- Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer (Q34575227) (← links)
- Telomere length in relation to immunological parameters in patients with renal cell carcinoma (Q34577167) (← links)
- IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. (Q34583514) (← links)
- The human T cell response to melanoma antigens (Q34587175) (← links)
- Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. (Q34610483) (← links)
- Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer (Q34618061) (← links)
- Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma. (Q34646640) (← links)
- Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples (Q34657644) (← links)
- Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2. (Q34657700) (← links)